Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Approval and delay status of United States -approved new drugs (2010-2023) in European Union, Japan, and China.

BMC health services research·2026
Same author

Sensitive detection of meat spoilage VOCs and visual monitoring of freshness <i>via</i> a UiO-66-NH<sub>2</sub>@MR nanocomposite-based colorimetric paper sensor.

The Analyst·2026
Same author

Intelligent quantification of Mn(VII) using a YOLO v3 artificial intelligence-driven smartphone monitoring platform based on nitrogen-doped blue fluorescence carbon dots.

The Analyst·2026
Same author

Nanozyme-Based Sensors: Advancing Antioxidant Analysis and Total Antioxidant Capacity Evaluation in Foods.

Critical reviews in analytical chemistry·2026
Same author

Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Long noncoding RNA SALTe1, microvascular ageing, and cardiac dysfunction.

European heart journal·2026

関連する実験動画

Updated: Feb 24, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.3K

骨肉腫に対するT細胞ベース免疫療法の進歩

Kun Zhang1, Zheng Wang2, Jiaqi He3

  • 1Department of Trauma Orthopedics, Shenzhen Longhua District People's Hospital, Shenzhen, China.

Frontiers in immunology
|February 23, 2026
PubMed
まとめ

骨肉腫の免疫療法は有望視されているが、免疫抑制やT細胞疲弊などの課題に直面している。将来の戦略は、この骨のがんにおけるより良い臨床転帰のために、T細胞機能と遊走の強化に焦点を当てている。

キーワード:
T細胞適応免疫免疫チェックポイント阻害剤免疫逃避免疫療法自然免疫骨肉腫

さらに関連する動画

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.6K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K

関連する実験動画

Last Updated: Feb 24, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

13.3K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.6K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.7K

科学分野:

  • 腫瘍学; 免疫学; がん研究

背景:

  • 骨肉腫は、転移性疾患の予後不良を伴う小児および青年期の原発性骨腫瘍である。現在の治療法は、特に再発性または転移性症例において、わずかな進歩しか提供していない。骨肉腫における免疫療法の有効性は、免疫抑制性の腫瘍微小環境とT細胞疲弊によって妨げられている。

研究 の 目的:

  • 骨肉腫に対するT細胞指向型免疫療法の最近の進歩をレビューすること。この分野におけるメカニズム的および臨床的進歩を検討すること。骨肉腫の治療成績を向上させるための将来の方向性を提案すること。

主な方法:

  • 骨肉腫に対するT細胞ベースの免疫療法に関する最近の文献のレビュー。γδT細胞、チェックポイント阻害剤、CAR T細胞などの戦略の前臨床および臨床データの分析。抗原提示、免疫細胞集団、T細胞遊走を含む治療効果を制限する要因の検討。

主要な成果:

  • T細胞ベースの戦略（γδ T細胞、チェックポイント阻害剤、CAR T細胞）は前臨床的な有望性を示しているが、臨床への応用は限定的である。抗原提示の障害、抑制性の免疫細胞、およびT細胞の遊走不良が免疫療法の有効性を制限している。これらの限界を理解することは、効果的な骨肉腫免疫療法の開発にとって重要である。

結論:

  • T細胞指向型免疫療法は、骨肉腫の治療に可能性を秘めている。免疫抑制性の腫瘍微小環境を克服し、T細胞機能を強化することが重要な課題である。将来の研究は、抗原提示の改善、免疫細胞集団の調節、および臨床的成功のためのT細胞遊走の最適化に焦点を当てるべきである。